A big volume day and for a while it looked to set a new low, but stock headed higher instead. All in all not a bad day as stock put in a higher low. Now, lets gets some results.
There has been some volume on the put and call side. My point was how expensive the aug series is. IV's are almost 200%. If you follow such things, thats huge, even for a bio and implies a binary event.
They were paying 25 cents for the aug 7 calls the other day. And 50 cents for the aug 3 puts today. Somethings going to happen very soon, but which way???
Just a guess. Its also possible china has good news and is not passing it on to rgrx in a timely fashion. JJ can do little until official from china. You just never know with those guys.
"those are all potential high price drug areas. Hair growth is not". Are you kidding? A company that has a no risk option for hair growth has a billion dollar market cap and beyond; instantly. Do you know what rogaine sells. And that doesnt even work.
As usual sno, you conclusions are so off the mark. RGRX can partner this indication out for big dollars if they can show benefit in humans(shouldnt be very hard or take long) and find an MOA.
Its not in market cap of RGRX at all and not a priority with all thats going on, but only up side here. Should hear from China this week or next; IMHO. But, lots of other positives to move share price going into the 2nd half of the year.
You got to be kidding me. That was the most unprofessional interview i have seen, and disrespectful. How many times do you have to use the word dispute? And how many times does he have to refute it? You mind as well be calling the guy a liar.
You could have asked so many questions about the science, but choose to go the "NY Post" route. You dont do the company or your rep much good. What a waste
The selling is extreme and not warranted. It is a direct result of forced selling by the highly leveraged closed end income funds. They are getting margin calls and cash demands from shareholders who are selling due to the expected fed rate rise. This is not company specific and is artificial selling that should be bought.
Cramer said this morning that MLP's will head higher when a firm(i am hearing about) "blows up." Fits in with comments the other day about leveraged closed end funds forced selling. In any event, non company specific selling and a nice, seemingly secure dividend, and possible M&A target say good place to buy.
Doesnt anyone here read the 8k's?? They just signed an agreement with Lincoln Park. They can put up to 10 million shares to them at anytime. They do not need an offering at this time. They can use Lincoln until stock price gets much higher.
All patents are meaningful to a little bio. RGRX has many, but how to monitize. ? G-treeBNT should buy rgrx. They have any inflated currency(their stock) and would make great sense to lock up all the indications rgrx has. If last transaction to get only 2 indications of TB4 are any metric for value, G-treeBNT would go much higher owning all. And they get a listing in the US, which they then could apply to OTC.
Its a crazy M & A market in the bio sector, this would really give them some exposure.(and wouldnt do rgrx shareholders any harm) What value? Who knows, but i wouldnt mind being a G-treeBNT holder.
Realistically, lots of events could push shares higher short term..china, Heart partnerships, cosmetics, G-treeBNT, more patents...........................
You have no clue. Company doesnt need to do offering. It has an agreement with Lincoln Park in place. They can put up to 10 million shares to them at market price anytime.
Uncharted territory; dont think so. You need to look at the 10 year chart to see where we are headed. Breakout here suggest a buck. Then, highs going back a couple years at 5.
This was the best early data at the conference. And if you believe management is credible, some risk has just been taken off the table and reward increased exponentially. Good luck and dont let mm's attempt at volitility scare you out of shares. This isnt even the 1st inning.
That news is being reported on CNBC and other venues and makes perfect sense. These leveraged closed end funds get margin calls on their holdings and must liquidate as stupid investors who bought them are being told by "advisors" to sell before the Fed raise. Its all wall st BS of the highest form.
And, selling breeds more selling.
Now known the source of unrelenting, mindless selling is coming form leveraged closed end income funds that MUST sell. This is not company specific. Just nonesense and will reward smart buyers here in the long run.
ANAVEX 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study, which consists of a 36-day on-off-on not-yet-optimized dosing regimen to assess bioavailability. At day 36, the amplitude of the cognitive EEG/ERP biomarker P300 increased 38 percent from baseline. Published data suggests that a 38 percent increase is approximately 4 times higher than donepezil (Aricept®), the current standard of care, in the same timeframe